Behavioral Activation for Serious Mental Illness
Trial Summary
What is the purpose of this trial?
The goal of this study is to evaluate the effectiveness of an behavioral activation intervention to increase meaningful activity and community participation for people with serious mental illness. The overall objective of this study is to increase engagement in meaningful activities and community participation. The objectives of the project are as follows: 1. To determine if the intervention leads to increases the frequency and variety of activities. 2. To determine if the intervention leads to increases in community mobility. 3. To determine which demographic and environmental factors and mechanisms of action impact the effectiveness of the intervention. 4. To determine if the the intervention leads to an improvement in overall well-being (e.g., improved quality of life). Participants will be asked to attend a 2-hour weekly online session for 10 weeks and then a 1-hour online monthly session for a 3 month maintenance period. For data collection, participants will also be asked to: 1. Complete three, approximately 1-hour interviews at baseline, after the 10 week intervention, and again at the end of the maintenance period; 2. Carry a mobile phone with a global positioning system app to track their movements outside their home for 2 weeks at a time, at three separate times (e.g., baseline, after the intervention, and at the end of the maintenance period); and 3. Complete a 15 minute weekly interviews for 26 weeks about their daily activities and participation. The study will enroll 52 participants split into 4 cohorts of 13. The study will use a multiple baseline design and, as such, all participants will receive the intervention and there is no control group.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral interventions, so you may not need to change your medication routine, but it's best to confirm with the study coordinators.
What data supports the effectiveness of the treatment Behavioral Activation for Serious Mental Illness?
Behavioral Activation (BA) is shown to be an effective treatment for depression by increasing engagement in positive activities, which can help improve mood. It has also been explored as a potential intervention for negative symptoms of schizophrenia, suggesting its broader applicability in mental health treatment.12345
Is Behavioral Activation safe for humans?
How is the treatment Behavioral Activation different from other treatments for serious mental illness?
Behavioral Activation is unique because it focuses on increasing engagement in positive activities to improve mood and mental health, rather than directly addressing negative thoughts or feelings. This approach is simple, effective, and can be applied to a wide range of mental health issues, making it a versatile option compared to more complex therapies.12568
Research Team
Eligibility Criteria
This trial is for individuals with serious mental illnesses like Schizoaffective Disorder, Schizophrenia, various forms of Depression, Bipolar Disorder, Psychosis, and Mood Disorders. Participants should be willing to engage in online sessions and use a GPS app to track movement.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants attend a 2-hour weekly online session for 10 weeks to increase meaningful activity and community participation
Maintenance
Participants attend a 1-hour online monthly session for a 3-month maintenance period
Follow-up
Participants are monitored for safety and effectiveness after the intervention and maintenance period
Treatment Details
Interventions
- Behavior Activation (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Temple University
Lead Sponsor
Dr. Kumar Budur
Temple University
Chief Medical Officer
MD, MS
Dr. Jeffrey M. Dayno
Temple University
Chief Executive Officer
MD from Temple University School of Medicine
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator
Dr. Kristi Hill
National Institute on Disability, Independent Living, and Rehabilitation Research
Acting Director since 2012
PhD in Neuroscience from the Medical College of Virginia
Dr. Phillip Beatty
National Institute on Disability, Independent Living, and Rehabilitation Research
Director of the Office of Research Sciences since 2019
PhD in Rehabilitation Sciences